References
- Ambs S, Prueitt RL, Yi M, et al (2008). Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res, 68, 6162-70. https://doi.org/10.1158/0008-5472.CAN-08-0144
- Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97. https://doi.org/10.1016/S0092-8674(04)00045-5
- Benjamini YH, Y (1995). Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the royal statistical society Series B (Methodological), 57, 289-300.
- Berezikov E, Guryev V, van de Belt J, et al (2005). Phylogenetic shadowing and computational identification of human microRNA genes. Cell, 120, 21-4. https://doi.org/10.1016/j.cell.2004.12.031
- Bubendorf L, Schopfer A, Wagner U, et al (2000). Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol, 31, 578-83. https://doi.org/10.1053/hp.2000.6698
- Chan JM, Jou RM, Carroll PR (2004). The relative impact and future burden of prostate cancer in the United States. J Urol, 172, S13-6; discussion S7. https://doi.org/10.1097/01.ju.0000142068.66876.53
- Cummins JM, He Y, Leary RJ, et al (2006). The colorectal microRNAome. Proc Natl Acad Sci U S A, 103, 3687-92. https://doi.org/10.1073/pnas.0511155103
- Ferrara N, Gerber HP, LeCouter J (2003). The biology of VEGF and its receptors. Nat Med, 9, 669-76. https://doi.org/10.1038/nm0603-669
- Garcia DM, Baek D, Shin C, et al (2011). Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat Struct Mol Biol, 18, 1139-46. https://doi.org/10.1038/nsmb.2115
- Gautier L, Cope L, Bolstad BM, Irizarry RA (2004). affy--analysis of Affymetrix GeneChip data at the probe level. Bioinformatics, 20, 307-15. https://doi.org/10.1093/bioinformatics/btg405
- Hao P, Chen X, Geng H, et al (2004). Expression and implication of hypoxia inducible factor-1alpha in prostate neoplasm. J Huazhong Univ Sci Technolog Med Sci, 24, 593-5. https://doi.org/10.1007/BF02911365
- Horvath S, Zhang B, Carlson M, et al (2006). Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci USA, 103, 17402-7. https://doi.org/10.1073/pnas.0608396103
- Iorio MV, Ferracin M, Liu CG, et al (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res, 65, 7065-70. https://doi.org/10.1158/0008-5472.CAN-05-1783
- Irizarry RA, Hobbs B, Collin F, et al (2003). Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics, 4, 249-64. https://doi.org/10.1093/biostatistics/4.2.249
- John B, Enright AJ, Aravin A, et al (2004). Human MicroRNA targets. PLoS Biol, 2, e363. https://doi.org/10.1371/journal.pbio.0020363
- Kanehisa M (2002). The KEGG database. Novartis Found Symp, 247, 91-101; discussion -3, 19-28, 244-52. https://doi.org/10.1002/0470857897.ch8
- Kimbro KS, Simons JW (2006). Hypoxia-inducible factor-1 in human breast and prostate cancer. Endocr Relat Cancer, 13, 739-49. https://doi.org/10.1677/erc.1.00728
- Kozomara A, Griffiths-Jones S (2011). miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res, 39, D152-7. https://doi.org/10.1093/nar/gkq1027
- Krek A, Grun D, Poy MN, et al (2005). Combinatorial microRNA target predictions. Nat Genet, 37, 495-500. https://doi.org/10.1038/ng1536
- Lee EJ, Gusev Y, Jiang J, et al (2007). Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer, 120, 1046-54.
- Lee RC, Feinbaum RL, Ambros V (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75, 843-54. https://doi.org/10.1016/0092-8674(93)90529-Y
- Linton DK, Hamdy FC (2004). Early diagnosis and surgical management of prostate cancer. Ann Urol (Paris), 38, 137-47. https://doi.org/10.1016/j.anuro.2004.06.001
- Logothetis CJ, Lin SH (2005). Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer, 5, 21-8. https://doi.org/10.1038/nrc1528
- Lu J, Getz G, Miska EA, et al (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834-8. https://doi.org/10.1038/nature03702
- Mattie MD, Benz CC, Bowers J, et al (2006). Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer, 5, 24. https://doi.org/10.1186/1476-4598-5-24
- McCarron SL, Edwards S, Evans PR, et al (2002). Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res, 62, 3369-72.
- Min H, Yoon S (2010). Got target? Computational methods for microRNA target prediction and their extension. Exp Mol Med, 42, 233-44. https://doi.org/10.3858/emm.2010.42.4.032
- Murakami Y, Yasuda T, Saigo K, et al (2006). Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene, 25, 2537-45. https://doi.org/10.1038/sj.onc.1209283
- O'Donnell KA, Wentzel EA, Zeller KI, et al (2005). c-Myc-regulated microRNAs modulate E2F1 expression. Nature, 435, 839-43. https://doi.org/10.1038/nature03677
- Ozen M, Creighton CJ, Ozdemir M, Ittmann M (2008). Widespread deregulation of microRNA expression in human prostate cancer. Oncogene, 27, 1788-93. https://doi.org/10.1038/sj.onc.1210809
- Porkka KP, Pfeiffer MJ, Waltering KK, et al (2007). MicroRNA expression profiling in prostate cancer. Cancer Res, 67, 6130-5. https://doi.org/10.1158/0008-5472.CAN-07-0533
- Schaefer A, Jung M, Miller K, et al (2010). Suitable reference genes for relative quantification of miRNA expression in prostate cancer. Exp Mol Med, 42, 749-58. https://doi.org/10.3858/emm.2010.42.11.076
- Schaefer A, Jung M, Mollenkopf HJ, et al (2010). Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer, 126, 1166-76.
- Semenza GL (2003). Targeting HIF-1 for cancer therapy. Nat Rev Cancer, 3, 721-32. https://doi.org/10.1038/nrc1187
- Sempere LF, Christensen M, Silahtaroglu A, et al (2007). Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res, 67, 11612-20. https://doi.org/10.1158/0008-5472.CAN-07-5019
- Sfar S, Hassen E, Saad H, et al (2006). Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome. Cytokine, 35, 21-8. https://doi.org/10.1016/j.cyto.2006.07.003
- Shen MM, Abate-Shen C (2010). Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev, 24, 1967-2000. https://doi.org/10.1101/gad.1965810
- Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29. https://doi.org/10.3322/caac.20138
- Szklarczyk D, Franceschini A, Kuhn M, et al (2011). The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res, 39, D561-8. https://doi.org/10.1093/nar/gkq973
- Team RDC (2011). R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing.
- Tong AW, Fulgham P, Jay C, et al (2009). MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther, 16, 206-16.
- van der Laan MJ, Dudoit S, Pollard KS (2004). Augmentation procedures for control of the generalized family-wise error rate and tail probabilities for the proportion of false positives. Stat Appl Genet Mol Biol, 3, Article15.
- Volinia S, Calin GA, Liu CG, et al (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA, 103, 2257-61. https://doi.org/10.1073/pnas.0510565103
- Wach S, Nolte E, Szczyrba J, et al (2012). MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening. Int J Cancer, 130, 611-21. https://doi.org/10.1002/ijc.26064
- Wang Y, Shao C, Shi CH, et al (2005). Change of the cell cycle after flutamide treatment in prostate cancer cells and its molecular mechanism. Asian J Androl, 7, 375-80. https://doi.org/10.1111/j.1745-7262.2005.00031.x
- Wightman B, Ha I, Ruvkun G (1993). Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell, 75, 855-62. https://doi.org/10.1016/0092-8674(93)90530-4
- Zhang JF, Fu WM, He ML, et al (2011). MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling. RNA Biol, 8.
- Zhong H, Agani F, Baccala AA, et al (1998). Increased expression of hypoxia inducible factor-1alpha in rat and human prostate cancer. Cancer Res, 58, 5280-4.
Cited by
- Overexpressed MicroRNA-182 Promotes Proliferation and Invasion in Prostate Cancer PC-3 Cells by Down-Regulating N-myc Downstream Regulated Gene 1 (NDRG1) vol.8, pp.7, 2013, https://doi.org/10.1371/journal.pone.0068982
- Regulatory Network Analysis of MicroRNAs and Genes in Neuroblastoma vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7645
- Identifying a Polymorphic ‘Switch’ That Influences miRNAs' Regulation of a Myasthenia Gravis Risk Pathway vol.9, pp.8, 2014, https://doi.org/10.1371/journal.pone.0104827
- MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer vol.184, pp.6, 2015, https://doi.org/10.1667/RR14185.1
- Mangiferin inhibition of proliferation and induction of apoptosis in human prostate cancer cells is correlated with downregulation of B-cell lymphoma-2 and upregulation of microRNA-182 vol.11, pp.1, 2015, https://doi.org/10.3892/ol.2015.3924
- MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer vol.17, pp.3, 2016, https://doi.org/10.3390/ijms17030421
- Novel MicroRNA Involved in Host Response to Avian Pathogenic Escherichia coli Identified by Deep Sequencing and Integration Analysis vol.85, pp.1, 2016, https://doi.org/10.1128/IAI.00688-16
- SNMDA: A novel method for predicting microRNA-disease associations based on sparse neighbourhood vol.22, pp.10, 2018, https://doi.org/10.1111/jcmm.13799